N-Pyridin-3-yl-4-3-[4-(trifluoromethyl)phenoxy]benzyl}piperazine-1-carboxamide is described, which is useful as a FAAH inhibitor. N-Pyridin-3-yl-4-3-[4-(trifluoromethyl)phenoxy]benzyl}piperazine-1-carboxamide may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). A method of synthesizing N-pyridin-3-yl-4-3-[4-(trifluoromethyl)phenoxy]benzyl}piperazine-1-carboxamide is also disclosed.
                            本文介绍了一种名为N-Pyridin-3-yl-4-3-[4-(三
氟甲基)苯氧基]苄基}
哌嗪-1-羧酰胺的物质,它可用作FAAH(
脂肪酸酰胺
水解酶)
抑制剂。N-Pyridin-3-yl-4-3-[4-(三
氟甲基)苯氧基]苄基}
哌嗪-1-羧酰胺可用于制备药物组合物和治疗由FAAH活性介导的疾病状态、疾患和症状,例如焦虑、疼痛、炎症、睡眠障碍、饮食障碍、能量代谢障碍和运动障碍(如多发性硬化)。本文还公开了一种合成N-pyridin-3-yl-4-3-[4-(三
氟甲基)苯氧基]苄基}
哌嗪-1-羧酰胺的方法。